Work

Preclinical Toxicology Supply for a Complex API Enabled by Asymmetric Catalysis and Rapid Chemical Development: IL-17A Inhibitor LY3509754

Year: 2025

Type: article

Source: Organic Process Research & Development

DOI: 10.1021/acs.oprd.4c00539

Authors: Thomas J. Beauchamp, Kevin P. Cole, Howard B. Broughton, David A. Coates, Graham Robert Cumming, Jose Eugenio de Diego, Kwame Frimpong, Julio Gutierrez, William Holloway, Ian Hotham, Spencer Jones, Talbi Kaoudi, Peter Lander, Adam M. Levinson, Yu Lu, Charles Lugar, Katherine Partridge, J. Craig Ruble, Sofiane Saouane, Narasimha Rao Ummaneni, H. George Vandeveer, Brian Watson

Institutions: Eli Lilly (United States), Eli Lilly (Spain), Albany Molecular Research (United States)

Language: English

Topic: Asymmetric Synthesis and Catalysis

Subfield: Organic Chemistry

Field: Chemistry

Domain: Physical Sciences

Open Access status: closed

OpenAlex ID: W4408185341

FWCI: 2.384

Cites: 36

Cited by: 8

Related to: 10